|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-4-4
|
|
pubmed:abstractText |
This study was carried out to determine the efficacy of and dose-response relationships to inhaled aerosolized prostacyclin (IAP), when used as a selective pulmonary vasodilator (SPV) in patients with severe hypoxemia due to ARDS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
117
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
819-27
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10713012-6-Ketoprostaglandin F1 alpha,
pubmed-meshheading:10713012-Administration, Inhalation,
pubmed-meshheading:10713012-Adult,
pubmed-meshheading:10713012-Aerosols,
pubmed-meshheading:10713012-Aged,
pubmed-meshheading:10713012-Anoxia,
pubmed-meshheading:10713012-Dose-Response Relationship, Drug,
pubmed-meshheading:10713012-Drug Administration Schedule,
pubmed-meshheading:10713012-Epoprostenol,
pubmed-meshheading:10713012-Female,
pubmed-meshheading:10713012-Hemodynamics,
pubmed-meshheading:10713012-Humans,
pubmed-meshheading:10713012-Male,
pubmed-meshheading:10713012-Middle Aged,
pubmed-meshheading:10713012-Oxygen,
pubmed-meshheading:10713012-Platelet Aggregation,
pubmed-meshheading:10713012-Prospective Studies,
pubmed-meshheading:10713012-Respiratory Distress Syndrome, Adult,
pubmed-meshheading:10713012-Treatment Outcome,
pubmed-meshheading:10713012-Vasodilator Agents
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS.
|
|
pubmed:affiliation |
Department of Pharmacology, University of Western Australia, Nedlands. vernon@iinet.net.au
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
